Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEP005 Gel in Seborrhoeic Keratosis
NCT01214564Phase 2Completed
- Sponsor
- Peplin
- Start
- Oct 2010
- Primary completion
- Dec 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ingenol mebutate in seborrheic keratosis (SK), sponsored by Peplin. Started Oct 2010; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
seborrheic keratosis (SK)
Beyond the preview
Go deeper on NCT01214564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01214564.